VAS & COVID-19: Frequently Asked Questions (FAQ)

These FAQ were developed to complement GAVA’s resources on vitamin A supplementation (VAS) in the context of the COVID-19 pandemic, including GAVA’s consensus statement and operational guide. The FAQ are organized by topic:

 

 

VITAMIN A AND COVID-19

 

MASS CAMPAIGNS VS. ROUTINE DELIVERY

 

HOUSEHOLD LEVEL (DOOR-TO-DOOR) VS. FIXED SITE DISTRIBUTION

 

HEALTH WORKER VS. CAREGIVER ADMINISTRATION MODEL

 

PREPARING FOR VAS DELIVERY

 

INTEGRATING VAS DELIVERY WITH OTHER HEALTH SERVICES

 

SCREENING FOR COVID-19

 

PERSONAL PROTECTIVE EQUIPMENT (MASKS, GLOVES, ETC.)

 

CAREGIVER ADMINISTRATION MODEL

 

TASK-SHIFTING TO COMMUNITY HEALTH WORKERS/VOLUNTEERS

 

SUPERVISION OF HEALTH WORKERS

 

DELIVERING VAS USING VITAMIN A SYRUP

Click here to download a PDF version of the FAQ.


 

Works Cited

[1] GAVA, “Administration of vitamin A supplementation for preschool-aged children in the context of COVID-19,” GAVA, 18 June 2020. [Online]. Available: http://www.gava.org/content/user_files/2020/06/GAVA-Operational-Guidance-VAS-in-the-context-of-COVID-19-1.pdf. [Accessed 18 June 2020].
[2] GAVA, “Universal vitamin A supplementation for preschool-aged children in the context of COVID-19: GAVA consensus statement,” GAVA, 22 June 2020. [Online]. Available: http://www.gava.org/content/user_files/2020/04/GAVA-Consensus-Statement-VAS-in-the-context-of-COVID-19-v.20200407.pdf. [Accessed 22 June 2020].
[3] WHO/UNICEF, “Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic,” 5 May 2020. [Online]. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Comm_health_care-2020.1. [Accessed 1 August 2020].
[4] WHO, “Global Surveillance for human infection with coronavirus disease (COVID-19),” WHO, March 20 2020. [Online]. Available: https://www.who.int/publications/i/item/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov). [Accessed 8 August 2020].
[5] WHO, “Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19) and considerations during severe shortages,” 6 April 2020. [Online]. Available: https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages. [Accessed 30 April 2020].
[6] WHO, “Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected,” 19 March 2020. [Online]. Available: https://www.who.int/publications/i/item/10665-331495. [Accessed 16 August 2020].
[7] WHO, “Maintaining essential health services: operational guidance for the COVID-19 context,” 1 June 2020. [Online]. Available: https://www.who.int/publications/i/item/10665-332240. [Accessed 1 August 2020].
[8] IFRC, “Supportive supervision during COVID-19,” May 2020. [Online]. Available: https://pscentre.org/wp-content/uploads/2020/05/Supportive-supervision-during-COVID-19.pdf. [Accessed 1 August 2020].
[9] UNICEF, “Social service workforce safety and wellbeing during the COVID-19 response: Recommended actions,” 2020. [Online]. Available: https://www.unicef.org/media/68501/file/Social-Service-Workforce-Safety-and-Wellbeing-during-COVID19-Response.pdf. [Accessed 1 August 2020].